These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9923652)

  • 1. New collagenolytic enzymes/cascade identified at the pannus-hard tissue junction in rheumatoid arthritis: destruction from above.
    Konttinen YT; Ceponis A; Takagi M; Ainola M; Sorsa T; Sutinen M; Salo T; Ma J; Santavirta S; Seiki M
    Matrix Biol; 1998 Dec; 17(8-9):585-601. PubMed ID: 9923652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis.
    Miller MC; Manning HB; Jain A; Troeberg L; Dudhia J; Essex D; Sandison A; Seiki M; Nanchahal J; Nagase H; Itoh Y
    Arthritis Rheum; 2009 Mar; 60(3):686-97. PubMed ID: 19248098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis.
    Goldbach-Mansky R; Lee JM; Hoxworth JM; Smith D; Duray P; Schumacher RH; Yarboro CH; Klippel J; Kleiner D; El-Gabalawy HS
    Arthritis Res; 2000; 2(2):145-53. PubMed ID: 11062605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis.
    Petrow PK; Wernicke D; Schulze Westhoff C; Hummel KM; Bräuer R; Kriegsmann J; Gromnica-Ihle E; Gay RE; Gay S
    Ann Rheum Dis; 2002 May; 61(5):391-7. PubMed ID: 11959761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of membrane-type 1 matrix metalloproteinase in rheumatoid synovial cells.
    Honda S; Migita K; Hirai Y; Origuchi T; Yamasaki S; Kamachi M; Shibatomi K; Fukuda T; Kita M; Hida A; Ida H; Aoyagi T; Kawakami A; Kawabe Y; Oizumi K; Eguchi K
    Clin Exp Immunol; 2001 Oct; 126(1):131-6. PubMed ID: 11678909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane-type-matrix metalloproteinase/matrix metalloproteinase-2/tissue inhibitor of metalloproteinase-2 system in periprosthetic connective-tissue remodeling in loose total-hip prostheses.
    Takagi M; Santavirta S; Ida H; Ishii M; Akimoto K; Saotome K; Konttinen YT
    Lab Invest; 1998 Jun; 78(6):735-42. PubMed ID: 9645764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junction and inhibition by alendronate.
    Konttinen YT; Salo T; Hanemaaijer R; Valleala H; Sorsa T; Sutinen M; Ceponis A; Xu JW; Santavirta S; Teronen O; López-Otín C
    Matrix Biol; 1999 Aug; 18(4):401-12. PubMed ID: 10517187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethylene.
    Nawrocki B; Polette M; Burlet H; Birembaut P; Adnet JJ
    J Bone Miner Res; 1999 Feb; 14(2):288-94. PubMed ID: 9933484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T; Yamanouchi K; Sato H; Tojo H; Seiki M; Tachi C
    Placenta; 2004 Nov; 25(10):810-9. PubMed ID: 15451196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in rheumatoid synovium.
    Yamanaka H; Makino K; Takizawa M; Nakamura H; Fujimoto N; Moriya H; Nemori R; Sato H; Seiki M; Okada Y
    Lab Invest; 2000 May; 80(5):677-87. PubMed ID: 10830778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H; Yokota K; Kurokawa Y; Murakami Y; Nishitani M; Kagawa S
    Cancer; 1998 Apr; 82(7):1359-66. PubMed ID: 9529029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines.
    Kurschat P; Zigrino P; Nischt R; Breitkopf K; Steurer P; Klein CE; Krieg T; Mauch C
    J Biol Chem; 1999 Jul; 274(30):21056-62. PubMed ID: 10409657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a latent soluble form of membrane type 1 matrix metalloprotease bound with tissue inhibitor of matrix metalloproteinases-2 in periprosthetic tissues and fluids from loose arthroplasty endoprostheses.
    Niarakis A; Giannopoulou E; Ravazoula P; Panagiotopoulos E; Zarkadis IK; Aletras AJ
    FEBS J; 2013 Dec; 280(24):6541-55. PubMed ID: 24112707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
    Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
    Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of pro-gelatinase A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells.
    Shofuda K; Moriyama K; Nishihashi A; Higashi S; Mizushima H; Yasumitsu H; Miki K; Sato H; Seiki M; Miyazaki K
    J Biochem; 1998 Aug; 124(2):462-70. PubMed ID: 9685743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive potential of human rheumatoid tenosynovial cells is in part MT1-MMP dependent.
    Jain A; Miller MC; Troeberg L; Itoh Y; Brennan F; Nanchahal J
    J Hand Surg Am; 2009 Sep; 34(7):1282-90. PubMed ID: 19596176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo.
    Hofmann UB; Westphal JR; Van Kraats AA; Ruiter DJ; Van Muijen GN
    Int J Cancer; 2000 Jul; 87(1):12-9. PubMed ID: 10861447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.